Health
Asian nations scale back AstraZeneca rollout amid safety woes – The Japan Times
The moves may delay protection for the region amid concerns that the shot could trigger a rare and potentially deadly blood clotting condition.
Countries across the Asia Pacific are demurring on AstraZeneca PLCs COVID-19 vaccine, or restricting its use, in moves that may delay protection for the region amid concerns that the shot could trigger a rare and potentially deadly blood clotting condition.
After guiding against the vaccines use in people under 50 and saying that it didnt expect shipments from Europe to arrive on time, Australias government abandoned a pledge that everyone in the country would receive a first dose by October.
In…
-
Noosa News23 hours agoMajor flood arrives at Birdsville
-
Business8 hours agoHow I’d build a $100,000 ASX portfolio from scratch
-
Business24 hours agoUS markets swung wildly last night. How extreme volatility can be a gift to ASX investors
-
General20 hours agoHow what happens on financial markets affects the broader economy